Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

15.26
BATS BZX Real-Time Price
As of 10:08am ET
 +0.15 / +0.99%
Today’s Change
13.00
Today|||52-Week Range
101.40
+5.10%
Year-to-Date
Frontrunning: January 18
Jan 18 / Investing Channel - Paid Partner Content
Valeant Pharmaceuticals: Separating Fact From Fiction
Jan 11 / MotleyFool.com - Paid Partner Content
Will This Be a Genius or Foolish Move for Johnson & Johnson?
Jan 13 / MotleyFool.com - Paid Partner Content
Trump: Drug companies 'getting away with murder'
Jan 11 / CNNMoney.com
Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News
Jan 13 / Zacks.com - Paid Partner Content
Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?...
Jan 11 / Zacks.com - Paid Partner Content
Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again
Jan 12 / Zacks.com - Paid Partner Content
This Is the Smartest Move Valeant Pharmaceuticals Has Made in a Really Long Time
Jan 11 / MotleyFool.com - Paid Partner Content
Valeant Streamlines Portfolio with Skincare Brands Sale
Jan 11 / Zacks.com - Paid Partner Content
Will This Cure What Ails Valeant Pharmaceuticals?
Jan 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close15.11
Today’s open15.30
Day’s range15.07 - 15.33
Volume112,116
Average volume (3 months)17,598,095
Market cap$5.2B
Dividend yield--
Data as of 10:08am ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-46.51%
Earnings growth (next 5 years)+9.40%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book0.88

Competitors

 Today’s
change
Today’s
% change
OPKOPKO Health Inc-0.23-2.56%
MNKMallinckrodt Plc+1.55+3.33%
IONSIonis Pharmaceutical...-0.54-1.15%
GRFSGrifols SA+0.16+0.96%
Data as of 10:08am ET, 01/19/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)$1.22
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts


Search for Jobs